Conditions: ADHD
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 276
Healthy volunteers: no

Brief summary:
The main aim of this study is to evaluate the long-term maintenance of efficacy of LDX after administered to children and adolescents aged 6-17 with ADHD for at least 6 months

Detailed description:

Arms:
arm 1: Open-label 30, 50, or 70mg arm 2: None

Interventions: intervention 1: Lisdexamfetamine dimesylate (LDX) intervention 2: Placebo
Intervention descriptions: intervention 1: LDX 30, 50, or 70mg capsule once per day (open-label and double-blind periods) intervention 2: Placebo capsule once per day (double-blind period)

Protocol document: